Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,590 | 0 |
| Depreciation Amortization | 5 | 0 |
| Other Working Capital | -220 | 0 |
| Other Operating Activity | 246 | 0 |
| Operating Cash Flow | $-1,560 | $0 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -3 | 0 |
| Investing Cash Flow | $-3 | $0 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 1,500 | 0 |
| Financing Cash Flow | $1,500 | $0 |
| Exchange Rate Effect | 20 | 0 |
| Beginning Cash Position | 200 | 0 |
| End Cash Position | 160 | 0 |
| Net Cash Flow | $-30 | $0 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,560 | 0 |
| Free Cash Flow | -1,560 | 0 |